Who makes [18F]F-ARAG PET?

[18F]F-ARAG PET is developed by CellSight Technologies, Inc..

Last reviewed 2026-04-19 · How we verify

[18F]F-ARAG PET

CellSight Technologies, Inc. · Phase 2 active Small molecule

At a glance

Generic name	[18F]F-ARAG PET
Sponsor	CellSight Technologies, Inc.
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

[18F]F-ARAG PET CI brief — competitive landscape report
[18F]F-ARAG PET updates RSS · CI watch RSS
CellSight Technologies, Inc. portfolio CI